MO‐F‐BRCD‐02: SBRT (Part 2): Physics and Quality Assurance Updates

Research output: Contribution to journalArticle

Abstract

The technical advantage of stereotactic body radiation therapy (SBRT) is based upon the ability to deliver a hypofractionated course of heterogeneous dose to a well‐defined volume with a rapid fall‐off of dose outside the treatment volume. The overall goal is to deliver an ablative dose to the target while minimizing the effects of radiation on the surrounding normal tissue. The major advantage of SBRT is the greater biologically effective dose to the target than that permitted by less conformal, fractionated techniques. In this presentation the established recommendations for quality assurance and safety of SBRT from ACR, ASTRO, and AAPM will be reviewed. The recommendations include establishing an SBRT clinic, equipment and imaging considerations, overview of staffing and personnel qualifications, treatment planning considerations, training, acceptance and commissioning practices, and use of safety checklists. Additionally, a Failure Mode and Effect Analysis (FMEA) for Stereotactic Body Radiation Therapy Delivery is presented. References: 1. Timothy D. Solberg PhD, James M. Balter PhD, Stanley H. Benedict PhD, Benedick A. Fraass PhD, Brian Kavanagh MD, Curtis Miyamoto MD, Todd Pawlicki PhD, Louis Potters MD, Yoshiya Yamada MD, “Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy” Practical Radiation Oncology (2011)2. Benedict SH, Yenice KM, Followill D, et al., “Stereotactic Body Radiation Therapy: The Report of AAPM Task Group 101” Med Phys. 2010;37:4078‐ 41013. Potters L, Kavanagh B, Galvin JM, et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2010;76:326–3324. Julian R. Perks PhD, Sinisa Stanic MD, Robin L Stern PhD, Barbara Henk RN MSN, Marsha S Nelson RN MBA, Rick D Harse RTT, Mathew Mathai BS CMD, James A Purdy PhD, Richard K Valicenti MD MA, Allan D Siefkin MD and Allen M Chen MD, “Failure Mode and Effect Analysis for Stereotactic Body Radiation Therapy Delivery” Int J Radiat Oncol Biol Phys. 2012 (in press) Learning Objectives: 1. Review and understand the ASTRO Recommendations for QA and Safety with SBRT 2. Review and understand the AAPM Task Group Recommendations for SBRT 3. Review and understand a FEMA Analysis of SBRT.

Original languageEnglish (US)
Pages (from-to)3873
Number of pages1
JournalMedical Physics
Volume39
Issue number6
DOIs
StatePublished - 2012

Fingerprint

Physics
Radiotherapy
Radiation Oncology
Safety
Radiology
Personnel Staffing and Scheduling
Songbirds
Radiosurgery
Radiation Effects
Checklist
Practice Guidelines
Learning

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

MO‐F‐BRCD‐02 : SBRT (Part 2): Physics and Quality Assurance Updates. / Perks, Julian R; Benedict, Stanley H.

In: Medical Physics, Vol. 39, No. 6, 2012, p. 3873.

Research output: Contribution to journalArticle

@article{965bdcd03bfe40f59a3fcd09bab950ef,
title = "MO‐F‐BRCD‐02: SBRT (Part 2): Physics and Quality Assurance Updates",
abstract = "The technical advantage of stereotactic body radiation therapy (SBRT) is based upon the ability to deliver a hypofractionated course of heterogeneous dose to a well‐defined volume with a rapid fall‐off of dose outside the treatment volume. The overall goal is to deliver an ablative dose to the target while minimizing the effects of radiation on the surrounding normal tissue. The major advantage of SBRT is the greater biologically effective dose to the target than that permitted by less conformal, fractionated techniques. In this presentation the established recommendations for quality assurance and safety of SBRT from ACR, ASTRO, and AAPM will be reviewed. The recommendations include establishing an SBRT clinic, equipment and imaging considerations, overview of staffing and personnel qualifications, treatment planning considerations, training, acceptance and commissioning practices, and use of safety checklists. Additionally, a Failure Mode and Effect Analysis (FMEA) for Stereotactic Body Radiation Therapy Delivery is presented. References: 1. Timothy D. Solberg PhD, James M. Balter PhD, Stanley H. Benedict PhD, Benedick A. Fraass PhD, Brian Kavanagh MD, Curtis Miyamoto MD, Todd Pawlicki PhD, Louis Potters MD, Yoshiya Yamada MD, “Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy” Practical Radiation Oncology (2011)2. Benedict SH, Yenice KM, Followill D, et al., “Stereotactic Body Radiation Therapy: The Report of AAPM Task Group 101” Med Phys. 2010;37:4078‐ 41013. Potters L, Kavanagh B, Galvin JM, et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2010;76:326–3324. Julian R. Perks PhD, Sinisa Stanic MD, Robin L Stern PhD, Barbara Henk RN MSN, Marsha S Nelson RN MBA, Rick D Harse RTT, Mathew Mathai BS CMD, James A Purdy PhD, Richard K Valicenti MD MA, Allan D Siefkin MD and Allen M Chen MD, “Failure Mode and Effect Analysis for Stereotactic Body Radiation Therapy Delivery” Int J Radiat Oncol Biol Phys. 2012 (in press) Learning Objectives: 1. Review and understand the ASTRO Recommendations for QA and Safety with SBRT 2. Review and understand the AAPM Task Group Recommendations for SBRT 3. Review and understand a FEMA Analysis of SBRT.",
author = "Perks, {Julian R} and Benedict, {Stanley H}",
year = "2012",
doi = "10.1118/1.4735813",
language = "English (US)",
volume = "39",
pages = "3873",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - MO‐F‐BRCD‐02

T2 - SBRT (Part 2): Physics and Quality Assurance Updates

AU - Perks, Julian R

AU - Benedict, Stanley H

PY - 2012

Y1 - 2012

N2 - The technical advantage of stereotactic body radiation therapy (SBRT) is based upon the ability to deliver a hypofractionated course of heterogeneous dose to a well‐defined volume with a rapid fall‐off of dose outside the treatment volume. The overall goal is to deliver an ablative dose to the target while minimizing the effects of radiation on the surrounding normal tissue. The major advantage of SBRT is the greater biologically effective dose to the target than that permitted by less conformal, fractionated techniques. In this presentation the established recommendations for quality assurance and safety of SBRT from ACR, ASTRO, and AAPM will be reviewed. The recommendations include establishing an SBRT clinic, equipment and imaging considerations, overview of staffing and personnel qualifications, treatment planning considerations, training, acceptance and commissioning practices, and use of safety checklists. Additionally, a Failure Mode and Effect Analysis (FMEA) for Stereotactic Body Radiation Therapy Delivery is presented. References: 1. Timothy D. Solberg PhD, James M. Balter PhD, Stanley H. Benedict PhD, Benedick A. Fraass PhD, Brian Kavanagh MD, Curtis Miyamoto MD, Todd Pawlicki PhD, Louis Potters MD, Yoshiya Yamada MD, “Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy” Practical Radiation Oncology (2011)2. Benedict SH, Yenice KM, Followill D, et al., “Stereotactic Body Radiation Therapy: The Report of AAPM Task Group 101” Med Phys. 2010;37:4078‐ 41013. Potters L, Kavanagh B, Galvin JM, et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2010;76:326–3324. Julian R. Perks PhD, Sinisa Stanic MD, Robin L Stern PhD, Barbara Henk RN MSN, Marsha S Nelson RN MBA, Rick D Harse RTT, Mathew Mathai BS CMD, James A Purdy PhD, Richard K Valicenti MD MA, Allan D Siefkin MD and Allen M Chen MD, “Failure Mode and Effect Analysis for Stereotactic Body Radiation Therapy Delivery” Int J Radiat Oncol Biol Phys. 2012 (in press) Learning Objectives: 1. Review and understand the ASTRO Recommendations for QA and Safety with SBRT 2. Review and understand the AAPM Task Group Recommendations for SBRT 3. Review and understand a FEMA Analysis of SBRT.

AB - The technical advantage of stereotactic body radiation therapy (SBRT) is based upon the ability to deliver a hypofractionated course of heterogeneous dose to a well‐defined volume with a rapid fall‐off of dose outside the treatment volume. The overall goal is to deliver an ablative dose to the target while minimizing the effects of radiation on the surrounding normal tissue. The major advantage of SBRT is the greater biologically effective dose to the target than that permitted by less conformal, fractionated techniques. In this presentation the established recommendations for quality assurance and safety of SBRT from ACR, ASTRO, and AAPM will be reviewed. The recommendations include establishing an SBRT clinic, equipment and imaging considerations, overview of staffing and personnel qualifications, treatment planning considerations, training, acceptance and commissioning practices, and use of safety checklists. Additionally, a Failure Mode and Effect Analysis (FMEA) for Stereotactic Body Radiation Therapy Delivery is presented. References: 1. Timothy D. Solberg PhD, James M. Balter PhD, Stanley H. Benedict PhD, Benedick A. Fraass PhD, Brian Kavanagh MD, Curtis Miyamoto MD, Todd Pawlicki PhD, Louis Potters MD, Yoshiya Yamada MD, “Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy” Practical Radiation Oncology (2011)2. Benedict SH, Yenice KM, Followill D, et al., “Stereotactic Body Radiation Therapy: The Report of AAPM Task Group 101” Med Phys. 2010;37:4078‐ 41013. Potters L, Kavanagh B, Galvin JM, et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2010;76:326–3324. Julian R. Perks PhD, Sinisa Stanic MD, Robin L Stern PhD, Barbara Henk RN MSN, Marsha S Nelson RN MBA, Rick D Harse RTT, Mathew Mathai BS CMD, James A Purdy PhD, Richard K Valicenti MD MA, Allan D Siefkin MD and Allen M Chen MD, “Failure Mode and Effect Analysis for Stereotactic Body Radiation Therapy Delivery” Int J Radiat Oncol Biol Phys. 2012 (in press) Learning Objectives: 1. Review and understand the ASTRO Recommendations for QA and Safety with SBRT 2. Review and understand the AAPM Task Group Recommendations for SBRT 3. Review and understand a FEMA Analysis of SBRT.

UR - http://www.scopus.com/inward/record.url?scp=85024788167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024788167&partnerID=8YFLogxK

U2 - 10.1118/1.4735813

DO - 10.1118/1.4735813

M3 - Article

AN - SCOPUS:85024788167

VL - 39

SP - 3873

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -